Anho Liem

Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.

J. Tijssen, A. Liem, D. V. van Veldhuisen, 2004, International journal of cardiology.

Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol

J. Jukema, S. Bergheanu, A. Liem, 2007, Current medical research and opinion.

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

Pedro F. Campos, Luciano Lopes de Sousa, Howard D. Rubenstein, 2023, European heart journal.

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.

Secondary prevention in coronary heart disease patients with low HDL: which options do we have?

J. Jukema, A. Liem, D. V. van Veldhuisen, 2003, International journal of cardiology.